膝下聚多卡醇静脉内微泡沫消融治疗大隐静脉和小隐静脉后与再通及再干预相关的因素
单中心回顾性研究纳入2018年3月至2023年7月411例患者573条患肢,接受1%聚多卡醇静脉内微泡沫消融治疗膝下大隐静脉和小隐静脉反流。平均随访231±329天,总体再通率10.6%,平均再通时间104±180天。静脉直径较大、男性、使用抗凝药与再通相关。
要点
- 膝下大隐静脉和小隐静脉聚多卡醇微泡沫消融总体再通率10.6%,平均随访231±329天。
- 再通静脉术前直径显著大于闭合静脉(再通4.9 mm vs 闭合4.3 mm,P=0.001)。
- 男性再通发生率高于女性(男性14.2% vs 女性8%,P=0.015),抗凝使用与再通相关(OR 1.96,95%CI 1.1-3.6,P=0.03)。
核心结论
- 聚多卡醇静脉内微泡沫消融治疗膝下大隐静脉和小隐静脉反流成功,平均231天闭合率89%,并显示作为挽救治疗的潜力。
- 大多数再通发生在术后早期,且与较低的聚多卡醇微泡沫用量相关。
- 较大的静脉直径、男性和抗凝使用与较高的再通率相关。
研究设计与样本
- 单中心回顾性研究,基于前瞻性维护的数据库,纳入接受1%聚多卡醇静脉内微泡沫消融治疗膝下大隐静脉和小隐静脉反流的患者。
- 2018年3月至2023年7月间,411例患者(166例男性,245例女性)共573条治疗肢体(右侧284条,左侧289条)符合研究标准。
- 排除消融后无超声随访的26例失访患者。
主要发现
- 573条纳入肢体中,457条(79.8%)既往接受过膝上大隐静脉消融。
- 共行554条膝下大隐静脉和42条小隐静脉消融,末次超声检查平均在231±329天。
- 总体再通率为10.6%(55条大隐静脉和8条小隐静脉),平均随访104±180天。
- 闭合静脉与再通静脉在年龄(P=0.90)、治疗侧别(P=0.14)、体重指数(P=0.59)、术前CEAP评分(P=0.79)、大隐静脉与小隐静脉再通率(P=0.06)及聚多卡醇微泡沫用量(P=0.24)方面无显著差异。
- 再通静脉术前直径显著大于闭合静脉(再通4.9 mm vs 闭合4.3 mm,P=0.001)。
关键数值与推荐
- 男性再通发生率高于女性(男性14.2% vs 女性8%,P=0.015)。
- 抗凝使用与再通相关(OR 1.96,95%CI 1.1-3.6,P=0.03)。
- 首次超声即发现的早期再通占31例失败(49.2%),其聚多卡醇微泡沫用量显著低于后期再通(早期4 mL vs 后期5 mL,P=0.025)。
- 33例再通患者需要再干预(52.4%),与30例不需要再干预者之间无显著差异。
- 共行24例再干预使用聚多卡醇微泡沫,中位160天(四分位距257天)时100%保持闭合。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Polidocanol endovenous microfoam (PEM) has been used to treat lower extremity venous reflux for almost one decade with specific advantages for below knee (BK) truncal veins where thermal ablation poses a risk of injury to adjacent nerves. The current literature of the BK segment often examines short-term outcomes with modest sample sizes. We aim to identify factors associated with recanalization and reintervention in this subset of patients. METHODS: We performed a retrospective study of a prospectively maintained database of patients from a single institution who underwent 1% PEM ablation for BK great saphenous vein (GSV) and small saphenous vein (SSV) reflux. Patients underwent duplex ultrasound (DU) within 7 days after injection, every 3 to 6 months for 1 year, and every 6 to 12 months thereafter. Patients with symptomatic recanalization underwent reintervention. The 26 patients lost to follow-up without DU after ablation were excluded. The factors associated with recanalization and reintervention were examined by multivariate and nonparametric analyses. RESULTS: Between March 2018 and July 2023, 411 patients (166 male, 245 female) with 573 treated limbs (284 right, 289 left) met the study criteria. Of the 573 included limbs, 457 (79.8%) had undergone prior above knee saphenous ablations. A total of 554 BK GSV and 42 SSV ablations were performed. The most recent DU was performed at a mean of 231 ± 329 days. The overall recanalization rate was 10.6% (55 GSVs and 8 SSVs) at a mean follow-up of 104 ± 180 days. Comparing the closed and recanalized veins, we found no significant difference in age (P = .90), treated laterality (P = .14), patient body mass index (P = .59), preprocedural CEAP (clinical-etiology-anatomy-pathophysiology) score (P = .79), recanalization rate in GSVs vs SSVs (P = .06), or administered PEM volume (P = .24). The recanalized veins had significantly larger preprocedural diameters than the veins that remained closed (recanalized, 4.9 mm; closed, 4.3 mm; P = .001). Men had higher incidence of recanalization than women (men, 14.2%; women, 8%; P = .015). Anticoagulation use was associated with recanalization (odds ratio, 1.96; 95% confidence interval, 1.1-3.6; P = .03). Early recanalization at the first DU accounted for 31 failures (49.2%) and had a significantly lower administered PEM volume compared with later recanalization (early, 4 mL; late, 5 mL; P = .025). There were no significant differences between the 33 recanalized patients requiring reintervention (52.4%) and the 30 who did not. Twenty-four reinterventions were performed with PEM, 100% of which remained closed at a median of 160 days (interquartile range, 257 days). CONCLUSIONS: PEM is successful for the treatment of BK GSV and SSV reflux with a closure rate of 89% at a mean of 231 days and shows promise as salvage therapy. Most cases of recanalization were noted in the early postprocedure period and were associated with a lower PEM volume. A larger vein diameter, male sex, and anticoagulation use are associated with higher rates of recanalization.
引用
- Fang J, Fang C, Moyal A, et al. Factors associated with recanalization and reintervention following below knee polidocanol endovenous microfoam ablation for great saphenous and small saphenous veins. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38580208. doi:10.1016/j.jvsv.2024.101886
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。